- Language: English
- Published: July 2012
- Region: Global
Global Biopharmaceuticals Market 2011-2015
- Published: July 2012
- Region: Global
- 57 pages
TechNavio's analysts forecast the Global Biopharmaceuticals market to grow at a CAGR of 4.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in RandD activities. However, patent expiration of top-selling drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Biopharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biopharmaceuticals landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Pfizer Inc., Abbott Laboratories Inc., Sanofi S.A., AstraZeneca plc, and Johnson and Johnson Services Inc. Other vendors in the market are GlaxoSmithKline plc, Merck Sereno S.A., UCB S.A., and Boehringer Ingelheim GmbH.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio Announces the Publication of its Report - Global Biopharmaceuticals Market 2011-2015
TechNavio today launched its report Global Biopharmaceuticals Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; “The Global Biopharmaceuticals market provides several growth opportunities for vendors because of the increasing demand for biopharmaceuticals across the globe. As a result, vendors in the market are investing heavily in the R&D of novel biologic components and to improve their efficacy in the treatment of different diseases. Similarly, vendors are increasingly investing in the R&D of effective drugs for the treatment of hepatitis C.”
According to the report, Monoclonal Antibodies is one of the major segments in the Global Biopharmaceuticals market. There is an increase in the use of monoclonal antibodies in various therapies such as radio-immunotherapy, antibody-directed enzyme prodrug therapy, and the formulation of biopharmaceutical drugs for the treatment of different diseases such as cancer, rheumatoid arthritis, multiple sclerosis, and ulcerative colitis. As a result, this has increased the revenue generation in the market.
Further, the report discusses that the patent expiry of top-selling drugs poses a challenge to the growth of the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players. SHOW LESS READ MORE >
01. Executive Summary
03. Market Coverage
04. Market Landscape
04.1 Global Monoclonal Antibodies Market
04.2 Global Growth Factors Market
04.3 Global Insulin Market
04.4 Global Growth Hormones Market
Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
Drivers and their Impact: End-users
Drivers and their Impact: Geography
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Pfizer Inc.
15.2 Abbott Laboratories Inc.
15.3 Sanofi S.A.
15.4 AstraZeneca plc
15.5 Johnson and Johnson Services Inc.
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Biologic Segmentation of the Global Biopharmaceuticals Market
Exhibit 2: Global Biopharmaceuticals Market 2011-2015 (US$ billion)
Exhibit 3: Global Biopharmaceuticals Market Segmentation by Biologic Components 2011
Exhibit 4: Global Biopharmaceuticals Market 2011-2015 (percent)
Exhibit 5: Global Biopharmaceuticals Market 2011-2015 (in US$ billion)
Exhibit 6: Global Monoclonal Antibodies Market 2011-2015 (US$ billion)
Exhibit 7: Global Growth Factors Market 2011-2015 (US$ billion)
Exhibit 8: Biologic Segmentation of the Global Growth Factors Market
Exhibit 9: Global Growth Factors Market Segmentation by Biologic Components 2011
Exhibit 10: Global Growth Factors Market 2011-2015 (percent)
Exhibit 11: Global Growth Factors Market 2011-2015 (in US$ billion)
Exhibit 12: Global Insulin Market 2011-2015 (US$ billion)
Exhibit 13: Global Growth Hormones Market 2011-2015 (US$ billion)
Exhibit 14: Global Biopharmaceuticals Market by Geographical Segmentation 2011
Exhibit 15: Hepatitis C Infection by Source in 2011
Exhibit 16: Global Biopharmaceuticals Market by Vendor Segmentation 2011
- Pfizer Inc.
- Abbott Laboratories Inc.
- Sanofi S.A
- AstraZeneca plc
- Johnson and Johnson Services Inc.
- GlaxoSmithKline plc
- Merck Sereno S.A.
- UCB S.A.
- Boehringer Ingelheim GmbH.